Pain Physician-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2024-04-14 1521ee135cm 来自浙江省

最近投稿网站进不去了，大家知道怎么回事吗

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2022-11-22 ms7000000471184589

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：疼痛;疼痛治疗技术;Meta分析
经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2023-02-16 ms7000000388634182 来自安徽省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：Manuscript received: 07-30-2022
Revised manuscript received:
10-10-2022
Accepted for publication:
10-14-2022
排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2019-05-14 cgzxzjy1_23539605

审稿速度:2.0
经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。

194 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2022-08-24 441246801

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：疼痛治疗技术
经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知

42 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2022-06-16 1e18b22bm01(暂无匿称)

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：疼痛;微创;Meta分析
经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2021-06-28 ms6000001442478095

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：微创;临床
经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。

76 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2021-12-14 12436392m12(暂无昵称)

审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0
偏重的研究方向：疼痛;麻醉;神经阻滞
经验分享：Manuscript received: 12-23-2020
Revised manuscript received:
04-06-2021
Accepted for publication:
04-19-2021
proof
08-11-2021
Free full manuscript

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2021-09-17 12591680m53暂无昵称

审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0
偏重的研究方向：meta分析
经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198362, encodeId=2eac21983620e, content=最近投稿网站进不去了，大家知道怎么回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Sun Apr 14 09:00:32 CST 2024, time=2024-04-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2101915, encodeId=c04c2101915cd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;疼痛治疗技术;Meta分析 经验分享：请问一下这个杂志是不是proof很慢？10月10号显示接收，到现在还没发proof给我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=133f5728127, createdName=ms7000000471184589, createdTime=Tue Nov 22 09:48:42 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114922, encodeId=7ddc2114922ba, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：Manuscript received: 07-30-2022 Revised manuscript received: 10-10-2022 Accepted for publication: 10-14-2022 排的2023年一月刊，但是不知道什么时候能检索到？等着找工作呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c8d8422152, createdName=ms7000000388634182, createdTime=Thu Feb 16 15:45:21 CST 2023, time=2023-02-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=570920, encodeId=ffbd5e0920ec, content=审稿速度:2.0 经验分享：2019.04.03投稿，04.08状态变为under review，05.10拒稿，没有任何审稿意见，应该是根本没有送出去审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62982186642, createdName=cgzxzjy1_23539605, createdTime=Tue May 14 18:19:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240797, encodeId=d0d91240e971d, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：疼痛治疗技术 经验分享：4月28投稿，6月28通知大修，7月15修回，8月21显示审稿结束，等待编辑意见，到现在一直没有消息，会不会是被拒绝？暂时还没邮件通知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIckhI6S0ybfMHAWnTvqAicWZStnqhuroxoXVoUNgsicFZcNfH29pKGvk74vowiadtS3jIzydl1J8YNA/132, createdBy=9e0b5274906, createdName=441246801, createdTime=Wed Aug 24 22:22:36 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226873, encodeId=510912268e308, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：疼痛;微创;Meta分析 经验分享：杂志社很不错，也没有版面费。现在投稿要200美金（大约）的审稿费了。录用后排了半年多上刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d89f1983618, createdName=1e18b22bm01(暂无匿称), createdTime=Thu Jun 16 19:57:29 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977713, encodeId=79d69e771393, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：微创;临床 经验分享：现在好像要审稿费了，我是2020年投的稿。审稿4个多月吧，修了一次，两个审稿专家意见一致倾向于接收，修会就直接接收了。这本杂志唯一吐槽的是，正式接收后等proof等了6个多月，快7个月，proof结束后基本当月就见刊了，但是正式见刊了马上就能在Pubmed上查到。跟编辑沟通早点proof，编辑的回复就是需要根据接收的顺序。这个杂志是双月刊，错过一期就得多等2个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/d0f2d426abdb4d41b90627cde91d6b35/d6a25e59666841099b1acda99023a976.jpg, createdBy=1ce65447396, createdName=ms6000001442478095, createdTime=Mon Jun 28 21:33:02 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080130, encodeId=659010801302b, content=审稿速度:3.0 | 投稿命中率:50.0 | 审稿费用:125.0 偏重的研究方向：疼痛;麻醉;神经阻滞 经验分享：Manuscript received: 12-23-2020 Revised manuscript received: 04-06-2021 Accepted for publication: 04-19-2021 proof 08-11-2021 Free full manuscript, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=90502470042, createdName=12436392m12(暂无昵称), createdTime=Tue Dec 14 23:41:27 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052461, encodeId=298b1052461e7, content=审稿速度:1.0 | 投稿命中率:50.0 | 审稿费用:100.0 偏重的研究方向：meta分析 经验分享：年初投了一篇，meta分析，比较中规中矩，大修了一次录用，但录用后七个月才给见刊。好在不需要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25cb2575514, createdName=12591680m53暂无昵称, createdTime=Fri Sep 17 23:49:28 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601034, encodeId=8459601034d5, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ebcd2974412, createdName=Bojack, createdTime=Mon Jun 01 21:50:15 CST 2020, time=2020-06-01, status=1, ipAttribution=)]

2020-06-01 Bojack

审稿速度:6.0 | 投稿命中率:75.0
经验分享：2019-9月投稿 19-11月回复审稿意见 20-2月份接受 4-6个月proof

145 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务